Study the prevalence of rifampicin resistance among pulmonary tuberculosis patients by genexpert assay from a tertiary care hospital of North India
Background: Rifampicin (RIF) resistance (RR) tuberculosis (TB) has posed a great challenge to TB control programs globally. Evidence of RIF-RR can help as a surrogate marker to find out multidrug-resistance cases. The study aimed to determine the prevalence of RIF-RR in pulmonary TB (PTB) patients...
Main Authors: | Jitendra Chandra Devrari, Madhu Chauhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2023;volume=12;issue=2;spage=175;epage=178;aulast=Devrari |
Similar Items
-
Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01) -
Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01) -
Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
by: Sepiso K. Masenga, et al.
Published: (2017-09-01) -
Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01) -
Evaluation of GeneXpert as a new diagnostic tool for detection of pulmonary tuberculosis
by: Mohamed A Tag Eldin, et al.
Published: (2019-01-01)